100 related articles for article (PubMed ID: 21596824)
1. Synthesis, biological studies of linear and branched arabinofuranoside-containing glycolipids and their interaction with surfactant protein A.
Naresh K; Bharati BK; Avaji PG; Chatterji D; Jayaraman N
Glycobiology; 2011 Sep; 21(9):1237-54. PubMed ID: 21596824
[TBL] [Abstract][Full Text] [Related]
2. Synthetic arabinomannan glycolipids and their effects on growth and motility of the Mycobacterium smegmatis.
Naresh K; Bharati BK; Avaji PG; Jayaraman N; Chatterji D
Org Biomol Chem; 2010 Feb; 8(3):592-9. PubMed ID: 20090975
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of β-arabinofuranoside glycolipids, studies of their binding to surfactant protein-A and effect on sliding motilities of M. smegmatis.
Naresh K; Avaji PG; Maiti K; Bharati BK; Syal K; Chatterji D; Jayaraman N
Glycoconj J; 2012 Apr; 29(2-3):107-18. PubMed ID: 22258791
[TBL] [Abstract][Full Text] [Related]
4. Synthetic Arabinomannan Heptasaccharide Glycolipids Inhibit Biofilm Growth and Augment Isoniazid Effects in Mycobacterium smegmatis.
Maiti K; Syal K; Chatterji D; Jayaraman N
Chembiochem; 2017 Oct; 18(19):1959-1970. PubMed ID: 28771901
[TBL] [Abstract][Full Text] [Related]
5. Synthetic arabinomannan glycolipids impede mycobacterial growth, sliding motility and biofilm structure.
Syal K; Maiti K; Naresh K; Avaji PG; Chatterji D; Jayaraman N
Glycoconj J; 2016 Oct; 33(5):763-77. PubMed ID: 27263096
[TBL] [Abstract][Full Text] [Related]
6. Mannopyranoside Glycolipids Inhibit Mycobacterial and Biofilm Growth and Potentiate Isoniazid Inhibition Activities in M. smegmatis.
Mahapa A; Samanta GC; Maiti K; Chatterji D; Jayaraman N
Chembiochem; 2019 Aug; 20(15):1966-1976. PubMed ID: 30951240
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and mycobacterial growth inhibition activities of bivalent and monovalent arabinofuranoside containing alkyl glycosides.
Naresh K; Bharati BK; Jayaraman N; Chatterji D
Org Biomol Chem; 2008 Jul; 6(13):2388-93. PubMed ID: 18563273
[TBL] [Abstract][Full Text] [Related]
8. Synthetic glycolipids and (p)ppGpp analogs: development of inhibitors for mycobacterial growth, biofilm and stringent response.
Syal K; Maiti K; Naresh K; Chatterji D; Jayaraman N
Adv Exp Med Biol; 2015; 842():309-27. PubMed ID: 25408352
[No Abstract] [Full Text] [Related]
9. Characterization of protein-glycolipid recognition at the membrane bilayer.
Evans SV; Roger MacKenzie C
J Mol Recognit; 1999; 12(3):155-68. PubMed ID: 10398406
[TBL] [Abstract][Full Text] [Related]
10. Proteomics and mass spectrometric studies reveal planktonic growth of Mycobacterium smegmatis in biofilm cultures in the absence of rpoZ.
Mukherjee R; Chatterji D
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):196-202. PubMed ID: 17822967
[TBL] [Abstract][Full Text] [Related]
11. [Sliding motility and biofilm formation in mycobacteria].
Recht J; Martínez A; Torello S; Kolter R
Acta Cient Venez; 2001; 52 Suppl 1():45-9. PubMed ID: 11899706
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of methyl 5-S-alkyl-5-thio-D-arabinofuranosides and evaluation of their antimycobacterial activity.
Sanki AK; Boucau J; Srivastava P; Adams SS; Ronning DR; Sucheck SJ
Bioorg Med Chem; 2008 May; 16(10):5672-82. PubMed ID: 18450455
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary collectins play distinct roles in host defense against Mycobacterium avium.
Ariki S; Kojima T; Gasa S; Saito A; Nishitani C; Takahashi M; Shimizu T; Kurimura Y; Sawada N; Fujii N; Kuroki Y
J Immunol; 2011 Sep; 187(5):2586-94. PubMed ID: 21821801
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of alpha-D-mannopyranoside glycolipid micelles-lectin interactions by surface plasmon resonance method.
Murthy BN; Voelcker NH; Jayaraman N
Glycobiology; 2006 Sep; 16(9):822-32. PubMed ID: 16782825
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of sugar-derived esters, alpha-ketoesters and alpha-ketoamides as inhibitors for Mycobacterium tuberculosis antigen 85C.
Sanki AK; Boucau J; Umesiri FE; Ronning DR; Sucheck SJ
Mol Biosyst; 2009 Sep; 5(9):945-56. PubMed ID: 19668859
[TBL] [Abstract][Full Text] [Related]
16. Glycodynamers: dynamic analogs of arabinofuranoside oligosaccharides.
Ruff Y; Lehn JM
Biopolymers; 2008 May; 89(5):486-96. PubMed ID: 18008321
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of octyl arabinofuranosides as substrates for mycobacterial arabinosyltransferases.
Han J; Gadikota RR; McCarren PR; Lowary TL
Carbohydr Res; 2003 Mar; 338(7):581-8. PubMed ID: 12644370
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of EGFR affinity to immobilized glycolipids by surface plasmon resonance.
Haga Y; Hakomori SI; Hatanaka K
Carbohydr Res; 2008 Dec; 343(18):3034-8. PubMed ID: 18828994
[TBL] [Abstract][Full Text] [Related]
19. Oligosaccharides as inhibitors of mycobacterial arabinosyltransferases. Di- and trisaccharides containing C-3 modified arabinofuranosyl residues.
Cociorva OM; Gurcha SS; Besra GS; Lowary TL
Bioorg Med Chem; 2005 Feb; 13(4):1369-79. PubMed ID: 15670944
[TBL] [Abstract][Full Text] [Related]
20. Gap, a mycobacterial specific integral membrane protein, is required for glycolipid transport to the cell surface.
Sondén B; Kocíncová D; Deshayes C; Euphrasie D; Rhayat L; Laval F; Frehel C; Daffé M; Etienne G; Reyrat JM
Mol Microbiol; 2005 Oct; 58(2):426-40. PubMed ID: 16194230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
